Almirall
2
7M
2
0.03
1
- Areas of investment
Summary
Almirall appeared to be the Corporate Investor, which was created in 1943. The leading representative office of defined Corporate Investor is situated in the Barcelona. The company was established in Europe in Spain.
The typical case for the fund is to invest in rounds with 1 participant. Despite the Almirall, startups are often financed by Polaris Partners, HealthCare Royalty Partners, Comerica Incorporated. In the next rounds fund is usually obtained by Essex Woodlands Healthcare Partners.
Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. Among the various public portfolio startups of the fund, we may underline Suneva Medical Among the most popular fund investment industries, there are Hospital, Health Care. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States.
The common things for fund are deals in the range of 10 - 50 millions dollars. The high activity for fund was in 2015. The fund is generally included in less than 2 deals every year.
Investments analytics
Analytics
- Total investments
- 2
- Lead investments
- 1
- Rounds per year
- 0.03
- Investments by industry
- Medical (2)
- Health Care (2)
- Hospital (1)
- Medical Device (1)
- Pharmaceutical (1) Show 6 more
- Investments by region
-
- United States (1)
- Switzerland (1)
- Peak activity year
- 2015
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 8
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
Company name | Deal date | Industry | Deal stage | Deal size | Location |
---|---|---|---|---|---|
Suneva Medical | 29 Jul 2015 | Health Care, Hospital, Medical Device, Medical | Late Stage Venture | 15M | United States, California, San Diego |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.